Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Leukemia, Myeloid, Acute 12Myelodysplastic Syndromes 11Hodgkin Disease 8Lymphoma, Non-Hodgkin 7Multiple Myeloma 6Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6Leukemia, Myelomonocytic, Chronic 5Myeloproliferative Disorders 4Lymphoma 4Leukemia, Lymphocytic, Chronic, B-Cell 4Leukemia 4Burkitt Lymphoma 4Anemia, Refractory, with Excess of Blasts 4Recurrence 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, Mantle-Cell 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, Follicular 3Leukemia, Myeloid, Accelerated Phase 3Leukemia, Biphenotypic, Acute 3Colorectal Neoplasms 3Blastic Plasmacytoid Dendritic Cell Neoplasm 3Stomach Neoplasms 2Sarcoma 2Primary Myelofibrosis 2Pancreatic Neoplasms 2Osteosarcoma 2Neuroblastoma 2Neoplasms, Plasma Cell 2

Interventions

Bevacizumab 21Paclitaxel 19Carboplatin 15pembrolizumab 14Specimen Handling 14liposomal doxorubicin 12Magnetic Resonance Spectroscopy 12Cyclophosphamide 11olaparib 10Gemcitabine 10fludarabine 9Topotecan 8Biopsy 8Fulvestrant 7niraparib 6Nivolumab 6palbociclib 5Taxes 5Immunoglobulin G 5Doxorubicin 5Disulfides 5aldesleukin 4trastuzumab deruxtecan 3mirvetuximab soravtansine 3binimetinib 3Oxaliplatin 3Cisplatin 3AZD5305 31-dodecylpyridoxal 3ulixertinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ovarian Neoplasms × fludarabine phosphate × 30 days × Clear all
NCT06305299 2026-05-19

Autologous CAR-T Cells Targeting B7H3 in Ovarian Cancer iC9-CAR.B7-H3 T Cells

UNC Lineberger Comprehensive Cancer Center

Phase 1 Recruiting
27 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡